slotkoers
Shanghai S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
10,3
CNY
|
+4,67%
|
|
+1,78%
|
-12,56%
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Marktkapitalisatie
1 |
26.923
|
16.001
|
23.297
|
37.203
|
29.860
|
19.194
|
Bedrijfswaarde
1 |
36.048
|
25.721
|
32.705
|
46.047
|
35.430
|
24.554
|
K/w-verhouding
|
18,6
x
|
21
x
|
19,4
x
|
13,4
x
|
13,8
x
|
15,7
x
|
Dividendrendement
|
1,02%
|
-
|
0,66%
|
0,9%
|
1,13%
|
1,19%
|
Marktkapitalisatie/omzet
|
1,92
x
|
0,83
x
|
1,31
x
|
2,2
x
|
1,63
x
|
1,32
x
|
Bedrijfswaarde/omzet
|
2,58
x
|
1,33
x
|
1,84
x
|
2,72
x
|
1,93
x
|
1,69
x
|
Bedrijfswaarde/EBITDA
|
57,4
x
|
25,6
x
|
31,2
x
|
57,4
x
|
22,8
x
|
15,6
x
|
Bedrijfswaarde/FCF
|
-38,5
x
|
-31,8
x
|
102
x
|
-18,3
x
|
-11,5
x
|
373
x
|
FCF Yield
|
-2,6%
|
-3,15%
|
0,98%
|
-5,45%
|
-8,71%
|
0,27%
|
Price to Book
|
1,34
x
|
0,79
x
|
1,08
x
|
1,55
x
|
1,07
x
|
0,67
x
|
Aantal aandelen (in duizenden)
|
1.529.710
|
1.529.710
|
1.529.710
|
1.529.710
|
1.529.710
|
1.524.577
|
Referentieprijs
2 |
17,60
|
10,46
|
15,23
|
24,32
|
19,52
|
12,59
|
Datum van publicatie
|
13/04/18
|
28/04/19
|
2/04/20
|
28/04/21
|
21/04/22
|
14/04/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Omzet
1 |
13.999
|
19.275
|
17.746
|
16.945
|
18.373
|
14.565
|
EBITDA
1 |
627,7
|
1.005
|
1.049
|
802,9
|
1.556
|
1.571
|
Bedrijfsresultaat (EBIT)
1 |
340
|
694,6
|
686
|
426
|
1.192
|
1.199
|
Operationele Marge
|
2,43%
|
3,6%
|
3,87%
|
2,51%
|
6,49%
|
8,24%
|
Resultaat voor belastingen (EBT)
1 |
1.621
|
982,9
|
1.486
|
2.699
|
2.634
|
1.715
|
Nettowinst (verlies)
1 |
1.446
|
761,8
|
1.202
|
2.771
|
2.159
|
1.224
|
Nettomarge
|
10,33%
|
3,95%
|
6,77%
|
16,35%
|
11,75%
|
8,4%
|
WPA
2 |
0,9454
|
0,4980
|
0,7857
|
1,812
|
1,412
|
0,8010
|
Free Cash Flow
1 |
-937,5
|
-809,9
|
320,6
|
-2.511
|
-3.088
|
65,89
|
FCF-marge
|
-6,7%
|
-4,2%
|
1,81%
|
-14,82%
|
-16,81%
|
0,45%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
30,57%
|
-
|
-
|
4,2%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
26,68%
|
-
|
-
|
5,39%
|
Dividend per aandeel
2 |
0,1800
|
-
|
0,1000
|
0,2200
|
0,2200
|
0,1502
|
Datum van publicatie
|
13/04/18
|
28/04/19
|
2/04/20
|
28/04/21
|
21/04/22
|
14/04/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Nettoschuldpositie
1 |
9.125
|
9.720
|
9.408
|
8.845
|
5.570
|
5.359
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
14,54
x
|
9,676
x
|
8,97
x
|
11,02
x
|
3,58
x
|
3,412
x
|
Free Cash Flow
1 |
-937
|
-810
|
321
|
-2.511
|
-3.088
|
65,9
|
ROE (netto-inkomsten/eigen vermogen)
|
7,2%
|
3,98%
|
5,97%
|
10,5%
|
8,81%
|
4,57%
|
ROA (netto-inkomsten/totale activa)
|
0,62%
|
1,22%
|
1,14%
|
0,68%
|
1,71%
|
1,56%
|
Totale activa
1 |
234.046
|
62.547
|
105.196
|
407.960
|
126.283
|
78.483
|
Nettoactief per aandeel
2 |
13,10
|
13,30
|
14,10
|
15,70
|
18,30
|
18,80
|
Cashflow per aandeel
2 |
1,470
|
1,570
|
1,390
|
1,390
|
3,660
|
5,680
|
Capex
1 |
845
|
500
|
760
|
330
|
614
|
647
|
Capex/omzet
|
6,04%
|
2,6%
|
4,28%
|
1,95%
|
3,34%
|
4,44%
|
Datum van publicatie
|
13/04/18
|
28/04/19
|
2/04/20
|
28/04/21
|
21/04/22
|
14/04/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -12,56% | 2,16 mld. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|